Werewolf Therapeutics Inc
General ticker "HOWL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $78.3M
Werewolf Therapeutics Inc does not follow the US Stock Market performance with the rate: -32.2%.
Estimated limits based on current volatility of 4.5%: low 1.48$, high 1.62$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Current price 21.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.99$, 5.23$]
- 2024-12-30 to 2025-12-30 estimated range: [2.44$, 6.04$]
Financial Metrics affecting the HOWL estimates:
- Negative: Non-GAAP EPS, $ of -1.04 <= 0.10
- Negative: Operating profit margin, % of -67.01 <= 1.03
- Negative: Operating cash flow per share per price, % of -24.49 <= 2.35
- Negative: negative Net income
- Negative: Inventory ratio change, % of 24.13 > 1.08
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term HOWL quotes
Long-term HOWL plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $16.40MM | $19.94MM |
| Operating Expenses | $50.09MM | $72.46MM | $60.45MM |
| Operating Income | $-50.09MM | $-56.06MM | $-40.50MM |
| Non-Operating Income | $0.10MM | $2.25MM | $3.13MM |
| Interest Expense | $0.00MM | $0.00MM | $3.14MM |
| R&D Expense | $35.27MM | $53.76MM | $41.78MM |
| Income(Loss) | $-49.98MM | $-53.81MM | $-37.37MM |
| Profit(Loss) | $-49.98MM | $-53.81MM | $-37.37MM |
| Stockholders Equity | $152.79MM | $122.34MM | $111.37MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $179.25MM | $160.25MM | $174.83MM |
| Operating Cash Flow | $-42.88MM | $-40.60MM | $-32.61MM |
| Capital expenditure | $0.50MM | $3.61MM | $0.77MM |
| Investing Cash Flow | $-0.50MM | $-3.61MM | $-0.77MM |
| Financing Cash Flow | $109.43MM | $15.91MM | $58.43MM |
| Earnings Per Share* | $-1.82 | $-1.79 | $-1.05 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.